论文部分内容阅读
inv(16)是急性髓系白血病(AML)M4Eo的特征性的异常核型,是预后较好的一个标志。inv(16)的结果是16q22上的CBFβ基因和16p13上的MYH11基因重排,产生CBFβ-MYH11融合基因,可能在白血病的发病机制中起重要作用。就inv(16)AML的临床、血液学特点及分子生物学特征等方面的研究进展作一综述。
Inv (16) is a characteristic abnormal karyotype of acute myeloid leukemia (AML) M4Eo and is a good prognostic marker. The result of inv (16) is that the CBFβ gene on 16q22 and MYH11 gene rearrangement on 16p13 produce the CBFβ-MYH11 fusion gene, which may play an important role in the pathogenesis of leukemia. The research progress of inv (16) AML in clinical, hematological characteristics and molecular biology are reviewed.